NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 129 filers reported holding NOVOCURE LTD in Q4 2017. The put-call ratio across all filers is 0.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $10,674,000 | -47.1% | 180,000 | -39.9% | 0.03% | -57.6% |
| Q1 2020 | $20,184,000 | -19.6% | 299,737 | +0.6% | 0.07% | +6.5% |
| Q4 2019 | $25,117,000 | +9.0% | 298,057 | -3.2% | 0.06% | +3.3% |
| Q3 2019 | $23,036,000 | -6.5% | 308,054 | -21.0% | 0.06% | -1.6% |
| Q2 2019 | $24,648,000 | -2.4% | 389,811 | -25.6% | 0.06% | -1.6% |
| Q1 2019 | $25,242,000 | -37.8% | 524,024 | -56.8% | 0.06% | -46.1% |
| Q4 2018 | $40,576,000 | -25.2% | 1,211,959 | +17.1% | 0.12% | -4.2% |
| Q3 2018 | $54,232,000 | +36.3% | 1,034,951 | -18.6% | 0.12% | +30.4% |
| Q2 2018 | $39,776,000 | +39.7% | 1,270,789 | -2.7% | 0.09% | +41.5% |
| Q1 2018 | $28,473,000 | +59.6% | 1,306,089 | +47.9% | 0.06% | +62.5% |
| Q4 2017 | $17,836,000 | – | 882,940 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |